We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+9.72%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22.3B
AUM Growth
+$2.03B
Cap. Flow
-$180M
Cap. Flow %
-0.81%
Top 10 Hldgs %
14.74%
Holding
1,485
New
211
Increased
524
Reduced
459
Closed
104

Top Buys

Rank Stock Value
1
CNH
CNH Industrial
CNH
+$187M
2
BKNG icon
Booking.com
BKNG
+$121M
3
COP icon
ConocoPhillips
COP
+$106M
4
PNC icon
PNC Financial Services
PNC
+$79M
5
HPQ icon
HP
HPQ
+$75.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$178M
2
HD icon
Home Depot
HD
+$143M
3
HES
Hess
HES
+$99M
4
UNP icon
Union Pacific
UNP
+$85.5M
5
MO icon
Altria Group
MO
+$84.4M

Sector Composition

Rank Sector Weight
1 Healthcare 15.42%
2 Financials 13.93%
3 Technology 12.88%
4 Industrials 10.85%
5 Energy 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
251
United Parcel Service
UPS
$88.9B
$18.6M 0.08%
176,588
-6,114
-3% -$602K
GLW icon
252
Corning
GLW
$107B
$18.4M 0.08%
1,031,867
-93,500
-8% -$1.54M
ECL icon
253
Ecolab
ECL
$79.8B
$18.3M 0.08%
175,315
+31,625
+22% +$3.29M
SSYS icon
254
Stratasys
SSYS
$666M
$18.2M 0.08%
135,000
-33,000
-20% -$3.82M
SLXP
255
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$18M 0.08%
200,230
-2,197
-1% -$175K
CBRL icon
256
Cracker Barrel
CBRL
$1.26B
$17.9M 0.08%
162,344
-13,900
-8% -$1.51M
VR
257
DELISTED
Validus Hold Ltd
VR
$17.9M 0.08%
443,461
-59,970
-12% -$2.34M
STT icon
258
State Street
STT
$48.4B
$17.7M 0.08%
240,867
-387
-0.2% -$27.1K
CI icon
259
Cigna
CI
$78.4B
$17.5M 0.08%
199,514
-6,518
-3% -$533K
PARA
260
DELISTED
Paramount Global Class B
PARA
$17.4M 0.08%
272,300
+8,200
+3% +$482K
INCY icon
261
Incyte
INCY
$25.4B
$17.4M 0.08%
342,727
-56,770
-14% -$2.47M
HON icon
262
Honeywell
HON
$76.4B
$17.2M 0.08%
209,068
+21,033
+11% +$1.64M
EWJ icon
263
iShares MSCI Japan ETF
EWJ
$21.2B
$17.1M 0.08%
352,228
-479,075
-58% -$22.8M
SLM icon
264
SLM Corp
SLM
$4.83B
$17.1M 0.08%
+1,817,021
New +$16.7M
AGN
265
DELISTED
Allergan Inc
AGN
$17.1M 0.08%
153,597
+21,769
+17% +$2.08M
VRTX icon
266
Vertex Pharmaceuticals
VRTX
$123B
$17.1M 0.08%
229,575
+25,616
+13% +$1.78M
REGN icon
267
Regeneron Pharmaceuticals
REGN
$72.9B
$17M 0.08%
61,709
-26,137
-30% -$7.52M
CAH icon
268
Cardinal Health
CAH
$53.7B
$16.8M 0.08%
252,055
+7,370
+3% +$450K
LUMN icon
269
Lumen
LUMN
$6.43B
$16.7M 0.07%
525,150
+226,500
+76% +$7.24M
TDG icon
270
TransDigm Group
TDG
$70.7B
$16.5M 0.07%
102,514
-6,965
-6% -$1.04M
SYK icon
271
Stryker
SYK
$135B
$16.5M 0.07%
219,008
+86,808
+66% +$6.33M
EA icon
272
Electronic Arts
EA
$52.4B
$16.4M 0.07%
716,850
+163,240
+29% +$3.92M
BBBY
273
DELISTED
Bed Bath & Beyond Inc
BBBY
$16.2M 0.07%
202,155
+28,915
+17% +$2.24M
ODFL icon
274
Old Dominion Freight Line
ODFL
$46.3B
$16.2M 0.07%
918,126
+211,860
+30% +$3.48M
ETR icon
275
Entergy
ETR
$50.3B
$16.2M 0.07%
512,748
-236,400
-32% -$7.53M

Similar funds

Axa's Q4 2013 Portfolio in Review

As of Q4 2013, Axa held 1,485 positions worth $22.3B, up 10% from $20.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q4 2013 filing shows 211 new, 524 increased, 459 reduced and 104 closed positions. Its largest new stake was CNH Industrial: 18,687,107 shares worth $185M. The largest sale was JPMorgan Chase, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • Axa's largest Q4 2013 buy was CNH Industrial: 18,687,107 shares worth $185M.
  • Axa added most to Booking.com in Q4 2013, an estimated $121M increase.
  • Axa's biggest Q4 2013 reduction was JPMorgan Chase, cutting an estimated $178M.
  • Axa fully exited Equinix in Q4 2013, selling an estimated $35.3M.
  • Axa's ten largest holdings make up 15% of its $22.3B portfolio in Q4 2013.
  • Axa opened 211 new positions and closed 104 in Q4 2013.
  • Axa's portfolio value rose 10% quarter-over-quarter to $22.3B.

Based on Axa's 13F filing for Q4 2013, filed 13 Feb 2014.